Pulmonary Hypertension Biorepository and Registry

Part of paid clinical trials in Kansas City, Kansas.

Sponsor
University of Kansas Medical Center
Study ID
NCT04808596
Status
Recruiting
Apply to this trial

Conditions

  • Chronic Thromboembolic Pulmonary Hypertension
  • Pulmonary Arterial Hypertension
  • Pulmonary Hypertension
  • Pulmonary Hypertension Due to Left Heart Disease
  • Pulmonary Hypertension Due to Lung Diseases and Hypoxia
  • Pulmonary Hypertension, Primary
  • Pulmonary Hypertension, Primary, 2
  • Pulmonary Hypertension, Primary, 3
  • Pulmonary Hypertension, Primary, 4

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Establish a pulmonary hypertension registry and biorepository to lead towards a further understanding of the disease.

Key Dates

Start date
Aug 10, 2020
Status verified
Jul 2025
Primary completion
Dec 31, 2026
Completion
Jul 31, 2027

Study Design

Enrollment
300 participants (estimated)

Primary Outcome Measure

Collect Clinical Data [ Time Frame: From Enrollment to 6 Months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Kansas Medical CenterKansas CityKansas66160
Luigi R Boccardi, Ed.D., MPH
[email protected]
9135884022
Kimberly Cygan, MBA, BSN, RN
[email protected]
Leslie A Spikes, MD (PRINCIPAL_INVESTIGATOR)
Lewis G Satterwhite, MD (SUB_INVESTIGATOR)
Timothy L Williamson, MD, FCCP (SUB_INVESTIGATOR)

Find similar trials in Kansas City, KS

By research site
University of Kansas Medical Center· Kansas City, KS

Related Studies